BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 223 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2022. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,132,608 | +79.7% | 69,629 | +162.9% | 0.03% | +100.0% |
| Q3 2022 | $1,743,000 | -14.4% | 26,484 | +33.6% | 0.02% | -28.6% |
| Q3 2021 | $2,037,000 | -33.1% | 19,818 | -27.0% | 0.02% | -48.8% |
| Q4 2020 | $3,044,000 | +411.6% | 27,137 | +323.0% | 0.04% | +272.7% |
| Q3 2020 | $595,000 | +141.9% | 6,415 | +108.7% | 0.01% | +83.3% |
| Q4 2019 | $246,000 | -90.1% | 3,074 | -90.9% | 0.01% | -91.8% |
| Q3 2019 | $2,484,000 | -81.6% | 33,800 | -76.4% | 0.07% | -84.8% |
| Q2 2019 | $13,536,000 | +38.6% | 143,500 | +17.6% | 0.48% | +41.3% |
| Q1 2019 | $9,766,000 | +853.7% | 122,000 | +797.9% | 0.34% | +303.6% |
| Q4 2017 | $1,024,000 | +43.4% | 13,588 | -23.9% | 0.08% | +16.7% |
| Q1 2017 | $714,000 | – | 17,849 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |